Biotech 2050 Podcast cover image

Navigating The Evolving Landscape of Inflammation Research, Scott Megaffin, CEO, Adiso Therapeutics

Biotech 2050 Podcast

CHAPTER

Advancing Drug Development and Team Building at Adiso Therapeutics

The chapter details the progress of Adiso Therapeutics in advancing their drug ADS-051 through Phase 1B and preparing for a Phase 2 trial, highlighting positive regulatory interactions and safety signals. It also explores the team building efforts at Adiso, emphasizing the importance of hiring skilled individuals with diverse expertise and values. Additionally, the chapter discusses strategic considerations for biotechs in partnering with big pharma and the significance of mentors, persistence, and patience in one's career.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner